Item 16. Form 10-K Summary.

5K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary.

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		CVS HEALTH CORPORATION
Date:	February 12, 2025	By:	/s/ THOMAS F. COWHEY
			Thomas F. Cowhey
			Executive Vice President and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Signature	Title(s)	Date

/s/ FERNANDO AGUIRRE	Director	February 12, 2025
Fernando Aguirre

/s/ JEFFREY R. BALSER, M.D., Ph.D.	Director	February 12, 2025
Jeffrey R. Balser, M.D., Ph.D.

/s/ C. DAVID BROWN II	Director	February 12, 2025
C. David Brown II

/s/ JAMES D. CLARK	Senior Vice President - Controller and Chief	February 12, 2025
James D. Clark	Accounting Officer (Principal Accounting Officer)

/s/ THOMAS F. COWHEY	Executive Vice President and Chief Financial Officer	February 12, 2025
Thomas F. Cowhey	(Principal Financial Officer)

/s/ ALECIA A. DECOUDREAUX	Director	February 12, 2025
Alecia A. DeCoudreaux

/s/ NANCY-ANN M. DEPARLE	Director	February 12, 2025
Nancy-Ann M. DeParle

/s/ ROGER N. FARAH	Chair of the Board and Director	February 12, 2025
Roger N. Farah

/s/ ANNE M. FINUCANE	Director	February 12, 2025
Anne M. Finucane

/s/ J. DAVID JOYNER	President and Chief Executive Officer	February 12, 2025
J. David Joyner	(Principal Executive Officer) and Director

/s/ J. SCOTT KIRBY	Director	February 12, 2025
J. Scott Kirby

/s/ MICHAEL F. MAHONEY	Director	February 12, 2025
Michael F. Mahoney

/s/ JEAN-PIERRE MILLON	Director	February 12, 2025
Jean-Pierre Millon

/s/ LESLIE V. NORWALK	Director	February 12, 2025
Leslie V. Norwalk

/s/ LARRY M. ROBBINS	Director	February 12, 2025
Larry M. Robbins

/s/ GUY P. SANSONE	Director	February 12, 2025
Guy P. Sansone

/s/ MARY L. SCHAPIRO	Director	February 12, 2025
Mary L. Schapiro

/s/ DOUGLAS H. SHULMAN	Director	February 12, 2025
Douglas H. Shulman

Previous: Item 15. Exhibits, Financial Statement Schedules.